- Master table of all cases included in the study.
| Age | Age at disease onset | Gender | ANA | SSA | SSB | RF | Lip biopsy | Pulmo-nary | Renal | Cuta-neous | Arthritis | PNS | Cyto-penia | CNS | PGA | PhGA | ESSDAI | ESSPRI for dryness | ESSPRI for fatigue | ESSPRI for pain | ESSPRI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18 | 16 | Female | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 7 | 0 | 6 | 8 | 3 | 5.7 |
| 34 | 29 | Female | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 2 | 7 | 1 | 0 | 1 | 0.7 |
| 39 | 32 | Female | 1 | 1 | 1 | 3 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 5 | 12 | 8 | 7 | 5 | 6.7 |
| 43 | 37 | Female | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 3 | 7 | 5 | 5 | 5 | 5 |
| 43 | 40 | Female | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 5 | 17 | 5 | 5 | 7 | 5.7 |
| 45 | 38 | Female | 1 | 1 | 1 | 3 | 3 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 2 | 2 | 14 | 9 | 3 | 0 | 4 |
| 49 | 42 | Male | 1 | 1 | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 0 | 3 | 3 | 2 | 2.7 |
| 50 | 46 | Female | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 7 | 0 | 10 | 10 | 10 | 10 |
| 50 | 47 | Female | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 3 | 12 | 5 | 1 | 1 | 2.3 |
| 52 | 48 | Female | 1 | 1 | 1 | 1 | 3 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 2 | 20 | 0 | 1 | 2 | 1 |
| 53 | 47 | Female | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 6 | 0 | 8 | 2 | 5 | 5 |
| 53 | 48 | Female | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 2 | 0 | 5 | 7 | 0 | 4 |
| 54 | 45 | Female | 1 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 4 | 1 | 2 | 6 | 4 | 0 | 3.3 |
| 54 | 46 | Female | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 7 | 19 | 8 | 7 | 10 | 8.3 |
| 55 | 48 | Female | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 7 | 10 | 2 | 5 | 1 | 2.7 |
| 55 | 50 | Female | 1 | 1 | 1 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 7 | 2 | 7 | 10 | 8 | 8.3 |
| 57 | 53 | Female | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 3 | 0 | 4 | 10 | 9 | 7.7 |
| 57 | 53 | Female | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 8 | 8 | 12 | 5 | 8 | 7 | 6.7 |
| 58 | 57 | Female | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 5 | 9 | 8 | 5 | 8 | 7 |
| 58 | 56 | Female | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 4 | 7 | 5 | 7 | 5 | 5.7 |
| 60 | 55 | Female | 1 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 9 | 1 | 3 | 4.3 |
| 60 | 50 | Female | 1 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 5 | 4 | 27 | 4 | 6 | 5 | 5 |
| 61 | 58 | Female | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 4 | 10 | 6 | 8 | 9 | 7.7 |
| 61 | 59 | Female | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 5 | 5 | 20 | 5 | 5 | 5 | 5 |
| 61 | 57 | Female | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | 7 | 5 | 3 | 5 | 4.3 |
| 63 | 59 | Female | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 9 | 6 | 34 | 10 | 8 | 8 | 8.7 |
| 64 | 61 | Female | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 6 | 10 | 5 | 9 | 9 | 7.7 |
| 65 | 54 | Female | 1 | 1 | 1 | 0 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 2 | 6 | 5 | 0 | 0 | 1.7 |
| 66 | 65 | Male | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 10 | 7 | 7 | 6 | 10 | 10 | 8.7 |
| 67 | 64 | Male | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 3 | 12 | 6 | 5 | 2 | 4.3 |
| 69 | 64 | Female | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 9 | 7 | 19 | 9 | 7 | 10 | 8.7 |
| 69 | 66 | Male | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 7 | 7 | 4 | 7 | 2 | 4.3 |
| 70 | 66 | Male | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 3 | 18 | 0 | 5 | 5 | 3.3 |
| 71 | 67 | Male | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 7 | 2 | 0 | 0 | 0.7 |
| 71 | 68 | Male | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 3 | 12 | 2 | 4 | 3 | 3 |
| 71 | 70 | Male | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 7 | 14 | 5 | 6 | 6 | 5.7 |
| 73 | 70 | Male | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 5 | 7 | 5 | 6 | 5 | 5.3 |
| 75 | 73 | Female | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 3 | 7 | 6 | 6 | 3 | 5 |
| 75 | 74 | Female | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 5 | 7 | 5 | 7 | 9 | 7 |
| 77 | 73 | Female | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 18 | 2 | 3 | 3 | 3.2 | |
| 83 | 79 | Female | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 9 | 6 | 9 | 0 | 5 | 7 | 4 |
ANA: antinuclear antibody, SSA: Sjogren’s syndrome A antibody, SSB: Sjogren’s syndrome B antibody, RF: rheumatoid factor, PNS: peripheral nervous system, CNS: central nervous system, PGA: patient global assessment, PhGA: physician global assessment, ESSDAI: EULAR Sjogren’s syndrome disease activity score, ESSPRI: EULAR Sjogren’s syndrome patient reported index